URGN
UroGen Pharma (URGN)
$98
About UroGen Pharma (URGN)
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.
Details
Daily high
$24.65
Daily low
$22.51
Price at open
$23.77
52 Week High
$30.00
52 Week Low
$3.42
Market cap
1.1B
Dividend yield
0.00%
Volume
847,655
Avg. volume
1.1M
P/E ratio
-6.64
UroGen Pharma News
Details
Daily high
$24.65
Daily low
$22.51
Price at open
$23.77
52 Week High
$30.00
52 Week Low
$3.42
Market cap
1.1B
Dividend yield
0.00%
Volume
847,655
Avg. volume
1.1M
P/E ratio
-6.64